Identification

Instrument name
Pixium Vision
Symbol
PIX
ISIN code
FR0011950641
Exchange / Market
Euronext
Handelssted
Paris
Products family
Stocks
Market organization
Euronext
Capitalization compartment
Compartment C
ICB
Medical Equipment

Operation

IPO date
ons 18/06/2014
IPO type
Initial Public offering
Catégorie
IPO
Capital raised
34

Selskapsdetaljer

Pixium Vision specializes in developing electronic retinal implants. Products are for people having lost their sight due to degenerative eye disorders such as retinitis pigmentosa.

Kilde: Cofisem - Sist oppdatert: 12 Jun 2023
Ledelse
Chief Executive Officer Lloyd Diamond
Director Research & Development Brian Burg
Chief Financial Officer Offer Nonhoff
Kilde: Cofisem - Sist oppdatert: 26 May 2023
Key figures
Millenium 2022 2021 2020 2019 2018
Net sales 0 0 0 0
Income from ordinary activities 1.830 1.615 1.383 1.718 1.323
Operating income -11.945 -10.260 -8.435 -8.870 -12.294
Cost of financial indebtedness net 576 651 685 883 921
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income -10.312 -10.930 -9.134 -9.876 -13.571
Net income (Group share) -10.312 -10.930 -9.134 -9.876 -13.571
Fiscal year end 12,22 12,21 12,20 12,19 12,18
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Kilde: Cofisem - Sist oppdatert: 12 Jun 2023
Største aksjonærer
Free float 90,29 %
EPIC Bpifrance 4,13 %
Sofinnova Capital VII FPCI 3,72 %
Abingworth Holdings Sarl 1,40 %
Bernard Gilly 0,23 %
Group-owned stock 0,23 %
Kilde: Cofisem - Sist oppdatert: 12 Jun 2023